iRadimed (NASDAQ:IRMD) CEO Roger E. Susi Sells 5,000 Shares

Key Points

• Roger Susi, CEO of iRadimed Corporation, sold 5,000 shares of stock for a total of $356,350 on September 17th, reducing his ownership by 0.21%.
• iRadimed recently declared a quarterly dividend of $0.17 per share, with an annualized dividend yield of 0.9%.
• Institutional investors hold 92.34% of iRadimed's stock, with several firms increasing their holdings notably in recent quarters.

iRadimed Corporation (NASDAQ:IRMD - Get Free Report) CEO Roger E. Susi sold 5,000 shares of the firm's stock in a transaction that occurred on Wednesday, September 17th. The shares were sold at an average price of $71.27, for a total transaction of $356,350.00. Following the completion of the transaction, the chief executive officer directly owned 2,357,500 shares of the company's stock, valued at $168,019,025. This represents a 0.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

iRadimed Stock Down 2.6%

IRMD stock traded down $1.86 during midday trading on Friday, hitting $70.52. The company's stock had a trading volume of 154,326 shares, compared to its average volume of 42,599. iRadimed Corporation has a 52-week low of $46.86 and a 52-week high of $74.43. The firm has a market capitalization of $897.01 million, a P/E ratio of 43.53 and a beta of 1.01. The firm has a 50-day simple moving average of $67.30 and a 200-day simple moving average of $59.15.

iRadimed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Monday, August 18th were given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Monday, August 18th. iRadimed's dividend payout ratio (DPR) is currently 41.98%.

Hedge Funds Weigh In On iRadimed

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. First Horizon Advisors Inc. boosted its position in iRadimed by 78.7% in the 1st quarter. First Horizon Advisors Inc. now owns 513 shares of the medical equipment provider's stock valued at $27,000 after buying an additional 226 shares during the period. Tower Research Capital LLC TRC boosted its position in iRadimed by 191.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 754 shares of the medical equipment provider's stock valued at $45,000 after buying an additional 495 shares during the period. Spire Wealth Management acquired a new stake in shares of iRadimed in the 2nd quarter valued at $60,000. US Bancorp DE raised its holdings in shares of iRadimed by 132.7% in the 1st quarter. US Bancorp DE now owns 1,436 shares of the medical equipment provider's stock valued at $75,000 after purchasing an additional 819 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new stake in shares of iRadimed in the 1st quarter valued at $78,000. Hedge funds and other institutional investors own 92.34% of the company's stock.

iRadimed Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.